Program Description
Many patients with diabetes do not meet glycemic targets, which can increase risk for complications that increase healthcare resource utilization and decrease patient quality of life. Research has indicated that patients whose diabetes is not adequately controlled are often adversely affected by health disparities and social determinants of health that prevent consistent utilization of healthcare treatment. The use of continuous glucose monitoring (CGM) devices are emerging as new, cost-effective standard of care options to be incorporated into diabetes management plans to enhance patient monitoring and, subsequently, patient outcomes. This supplement will examine real-world evidence and cost-savings models utilizing CGM to assist managed care pharmacists in developing strategies to minimize costs and access barriers associated with CGM for patients with diabetes.
Target audience: Managed care pharmacists, health system pharmacists, and retail pharmacists
Type of activity: Application
Release date: July 11, 2022
Expiration date: July 11, 2023
Time to complete activity: 3.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine the guideline recommendations and recent data on the clinical benefits and optimal use of continuous glucose monitoring (CGM) for the management of diabetes.
- Explore the social determinants of health that negatively affect patients with diabetes and strategies to promote health equity.
- Investigate the value of CGM in optimizing the management of diabetes and opportunities to promote access to appropriate patients.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
